| Gina Terorde, MS CCC-SLP | |
|
2520 Regency Rd Ste 150, Lexington, KY 40503-2921 | |
| (859) 224-0834 | |
| Not Available |
| Full Name | Gina Terorde |
|---|---|
| Gender | Female |
| Speciality | Speech-language Pathologist |
| Location | 2520 Regency Rd Ste 150, Lexington, Kentucky |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1043709629 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 235Z00000X | Speech-language Pathologist | 174368 (Kentucky) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Gina Terorde, MS CCC-SLP 2520 Regency Rd Ste 150, Lexington, KY 40503-2921 Ph: () - | Gina Terorde, MS CCC-SLP 2520 Regency Rd Ste 150, Lexington, KY 40503-2921 Ph: (859) 224-0834 |
News Archive
Using whole genomic sequencing, scientists from RIKEN in Japan have for the first time demonstrated the profound effect that chronic hepatitis infection and inflammation can have on the genetic mutations found in tumors of the liver, potentially paving the way to a better understanding of the mechanisms through which these chronic infections can lead to cancer.
Emmaus Medical, Inc., a pharmaceutical company developing a new treatment for sickle cell disease, and subsidiary of Emmaus Life Sciences, Inc., announced today that its investigational L-glutamine treatment for sickle cell disease has received a positive opinion recommending orphan medicinal product designation by the European Medicines Agency's (EMA) Committee for Orphan Medicinal Products (COMP). The designation allows Emmaus ten years of marketing exclusivity in EU member countries after the product obtains marketing authorization, as well as streamlined regulatory review processes and registration and other fee reductions.
Shortages of prescription drugs are leaving a growing number of patients waiting for life-saving medicines. Federal officials say the number of prescriptions in short supply tripled from 2005 to 2010. Limited supplies of some drugs have sent prices soaring 1,000 times above normal.
A new study published on the preprint server medRxiv* in June 2020 reports that obesity is a risk factor of composite poor outcome of COVID-19 disease. On the other hand, COVID-19 patients with 'composite poor outcome' have higher BMI. Therefore, BMI should be assessed in the management of COVID-19 patients, and special attention should be given to patients with obesity.
› Verified 7 days ago
Kathleen Shelton, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 3365 Hunting Hills Ct, Lexington, KY 40515 Phone: 859-576-4807 | |
Mrs. Jessica Sanders Roberts, M.A, CCC SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 2412 Greatstone Pt, Lexington, KY 40504 Phone: 859-224-4081 | |
Mrs. Erica Keller Musgrave, M.S., CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 882 Mcmeekin Pl, Lexington, KY 40502 Phone: 859-619-5259 | |
Melena Dailey, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 2412 Greatstone Pt, Lexington, KY 40504 Phone: 859-224-4081 | |
Barbara Shaw, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 700 Mason Headley Rd, Lexington, KY 40504 Phone: 859-276-1083 | |
Christina Johnson, SLP Speech-Language Pathologist Medicare: Medicare Enrolled Practice Location: 1165 Monarch St, Lexington, KY 40513 Phone: 859-335-7980 | |
Mrs. Amanda Moore Chastain, M.A., CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 2035 Regency Rd, Suite 5, Lexington, KY 40503 Phone: 859-402-1553 Fax: 859-402-1553 |